טוען...
Cardiac metabolism as a driver and therapeutic target of myocardial infarction
Reducing infarct size during a cardiac ischaemic‐reperfusion episode is still of paramount importance, because the extension of myocardial necrosis is an important risk factor for developing heart failure. Cardiac ischaemia‐reperfusion injury (IRI) is in principle a metabolic pathology as it is caus...
שמור ב:
| הוצא לאור ב: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294140/ https://ncbi.nlm.nih.gov/pubmed/32384583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15180 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|